IDXX
IDEXX Laboratories·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 1
Consensus Rating "Buy"
High Gross Profit Margin
High Cash/net Profit Ratio
EPS Beats Expectation
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About IDXX
Idexx Laboratories, Inc.
A global leading developer of diagnostic products and services for the veterinary market
Healthcare Equipment and Supplies
--
06/21/1991
NASDAQ Stock Exchange
11,000
12-31
Common stock
One IDEXX Drive, Westbrook, Maine 04092
Development and production of medical instruments and equipment
IDEXX Laboratories was incorporated in Delaware in 1983. The company mainly develops, manufactures and distributes products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. The company also provides human medical immediate care and laboratory diagnosis.
Earnings Call
Q1/2025
Estimate EPS2.84
Actual EPS2.91
Estimate Revenue996.47M
Actual Revenue998.43M
IDEXX's Q1 2025: Dissecting Contradictions in Pet Owner Demand, Economic Impact, and Financial Outlook
May 13,2025 11:09
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS3.3
Actual EPS3.63
Estimate Revenue1.07B
Actual Revenue1.11B
IDEXX's 2025 Outlook: Contradictions in InVue Placements, Cancer Dx Growth, and Market Dynamics
Aug 04,2025 02:44
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS3.14
Actual EPS3.22
Estimate Revenue1.07B
Actual Revenue1.10B
IDEXX Laboratories Q3 2025: Contradictions Emerge on InVue Placement Projections, International CAG Diagnostics Growth, and Macroeconomic Impact
Nov 03,2025 11:45
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
IDXX has released its 2025 Q3 earnings. EPS was reported at 3.22, versus the expected 3.14, beating expectations. The chart below visualizes how IDXX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
IDXX has released its 2025 Q3 earnings report, with revenue of 1.11B, reflecting a YoY change of 13.29%, and net profit of 274.61M, showing a YoY change of 17.94%. The Sankey diagram below clearly presents IDXX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
